✦ LIBER ✦
439 Significantly Higher Pathologic Complete Response Rate with Weekly Compared with Three-weekly Paclitaxel and Carboplatin Plus Trastuzumab Neoadjuvant Therapy – Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer
✍ Scribed by Z.M. Shao; C.M. Chen; Y. Zhou; S. Chen; Y.F. Hou; G.Y. Liu; G.H. Di; J.S. Lu; J. Wu; Z.Z. Shen
- Book ID
- 117662346
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 59 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.